Kissei Pharm. Co. Ltd. v. Sandoz Inc., 13-1092 (D. Del.)
Rapaflo® (silodosin capsules)
5,387,603
N/A
Shire LLC v. Amerigen Pharms. Ltd., 14-6095 (D.N.J.)
Adderall® XR (amphetamine / dextroamphetamine)
RE41,148 RE42,096
Defendant acknowledges that patents-in-suit are valid and enforceable; that selling a generic version of Adderall XR would infringe those patents; and until patent expiration, Defendant can only sell a generic product with Plaintiff’s permission.
PDL BioPharma Inc. v. Merck Sharp & Dohme Corp., 16-0407 (D.N.J.)
Keytruda® (pembrolizumab for injection)
5,693,761
Merck will pay $19.5 million to license related patent rights and dismiss the case; and PDL agreed to not sue Merck for royalties related to Keytruda in the future.
When you visit our website, we use cookies on your browser to collect information. The information collected might relate to you, your preferences, or your device, and is mostly used to make the site work as you expect it to and to provide a more personalized web experience. For more information about how we use Cookies, please see our Privacy Policy.
Strictly Necessary Cookies
Always Active
Necessary cookies enable core functionality such as security, network management, and accessibility. These cookies may only be disabled by changing your browser settings, but this may affect how the website functions.
Functional Cookies
Always Active
Some functions of the site require remembering user choices, for example your cookie preference, or keyword search highlighting. These do not store any personal information.
Form Submissions
Always Active
When submitting your data, for example on a contact form or event registration, a cookie might be used to monitor the state of your submission across pages.
Performance Cookies
Performance cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.
Counsel
